The prevalence of EML4-ALK variants in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
Conclusion: This present study provides the exact prevalence of EML4-ALK rearrangement in different variants for NSCLC patients with ALK positive.
PMID: 31432686 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Internal Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Study